As we explore new health and wellness trends, we commit to staying informed and guided by evidence-based practices
There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide sold as Mounjaro, Ozempic, Wegovy and Zepound lower the risk of cardiovascular diseases protect the kidney and the liver, reduce inflammation and pain, prevent addiction and substance abuse, help people with arthritis and those with sleep apnea
Accelerating recovery: Animal studies suggest faster healing, reduced recovery times, and improved functional outcomes after injuries
Physiological Reviews
2 , 699706.e691 (2020)
In the SURMOUNT-1 trial (N=2,539) of tirzepatide, GI adverse events led to treatment discontinuation in only 4.3-7.1% of participants across dose groups 21, suggesting that most side effects including those downstream of GI symptoms like cramping are manageable without stopping therapy